We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
ITIH4
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • ITIH4
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

ITIH4 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 353.17
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 656.9
Number of samples 362
Samples
Sample Description pTPM
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 3534.6
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 3297.0
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 2747.9
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 2566.8
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 1991.6
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 1871.5
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 1842.5
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 1826.1
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 1787.3
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 1734.6
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 1692.6
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 1660.9
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 1625.2
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 1619.0
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 1615.6
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 1611.6
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 1593.1
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 1587.0
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 1583.5
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 1501.6
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 1482.9
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 1445.6
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 1440.8
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 1440.4
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 1431.7
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 1408.3
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 1402.3
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 1396.7
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 1388.2
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 1383.8
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 1378.5
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 1376.7
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 1375.5
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 1352.4
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 1316.4
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 1301.1
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 1297.8
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 1280.5
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 1280.4
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 1278.5
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 1268.7
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 1257.7
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 1255.0
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 1224.5
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 1209.8
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 1205.1
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 1204.6
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 1203.5
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 1200.5
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 1199.0
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 1191.8
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 1191.2
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 1177.7
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 1172.1
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 1165.7
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 1157.6
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 1154.5
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 1122.2
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 1098.9
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 1096.9
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 1069.4
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 1068.4
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 1065.2
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 1064.8
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 1042.5
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 1039.1
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 1037.7
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 1036.2
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 1018.9
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 1007.3
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 987.8
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 984.6
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 983.2
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 979.2
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 974.3
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 973.2
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 973.1
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 972.0
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 963.7
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 949.0
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 948.4
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 945.5
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 944.0
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 942.4
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 934.0
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 930.5
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 925.8
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 921.3
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 908.9
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 908.8
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 901.8
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 898.7
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 896.2
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 889.6
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 875.5
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 871.2
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 868.9
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 866.7
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 866.6
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 860.9
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 858.9
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 857.8
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 857.5
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 849.4
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 844.2
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 842.8
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 840.4
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 839.8
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 825.6
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 818.8
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 814.7
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 812.1
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 808.3
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 802.1
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 802.0
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 800.0
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 797.5
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 781.0
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 780.2
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 780.1
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 775.0
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 771.8
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 769.7
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 762.7
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 761.0
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 760.6
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 748.4
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 743.2
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 743.2
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 739.6
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 736.1
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 731.1
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 730.1
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 729.3
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 726.4
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 726.3
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 720.5
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 720.2
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 715.0
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 711.4
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 711.2
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 706.6
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 703.9
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 699.1
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 696.2
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 695.9
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 693.6
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 690.3
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 688.5
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 685.0
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 680.3
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 677.9
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 673.8
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 672.5
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 669.2
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 662.6
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 661.9
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 660.4
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 657.4
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 653.2
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 652.5
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 646.8
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 645.8
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 623.6
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 616.2
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 612.9
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 610.1
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 609.9
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 606.7
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 600.6
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 600.0
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 597.0
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 596.9
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 593.5
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 588.4
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 586.2
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 583.3
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 582.7
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 581.4
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 579.1
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 576.3
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 575.8
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 573.9
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 571.6
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 570.7
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 568.3
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 561.0
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 549.5
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 548.2
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 541.6
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 531.4
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 525.3
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 523.5
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 523.4
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 523.2
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 520.9
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 519.2
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 512.1
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 510.6
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 509.9
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 506.3
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 504.4
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 502.4
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 498.0
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 495.0
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 485.0
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 478.3
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 457.4
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 456.6
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 456.3
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 454.8
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 452.8
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 451.4
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 450.7
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 446.4
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 445.0
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 444.1
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 437.7
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 437.7
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 437.1
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 436.9
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 435.6
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 432.0
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 426.0
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 414.5
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 412.5
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 406.5
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 404.7
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 404.4
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 403.9
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 397.7
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 397.3
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 393.6
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 393.6
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 392.1
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 385.6
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 385.4
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 383.3
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 380.7
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 379.7
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 364.7
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 363.3
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 359.8
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 358.6
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 353.2
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 352.1
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 351.0
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 348.8
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 347.4
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 345.2
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 341.1
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 337.2
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 335.1
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 331.9
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 330.4
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 327.5
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 327.3
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 326.4
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 324.7
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 324.3
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 322.9
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 322.0
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 316.4
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 313.1
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 312.8
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 303.1
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 303.0
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 298.0
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 294.7
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 290.6
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 286.3
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 285.2
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 281.0
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 276.0
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 275.7
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 270.9
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 265.4
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 263.7
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 257.7
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 254.8
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 252.6
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 250.5
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 249.5
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 247.4
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 243.2
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 242.4
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 232.6
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 229.9
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 229.6
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 225.8
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 225.0
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 222.1
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 222.1
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 219.7
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 219.2
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 219.2
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 218.3
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 216.0
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 209.3
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 208.5
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 207.9
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 207.5
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 202.6
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 202.0
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 195.6
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 189.6
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 189.6
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 187.1
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 186.7
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 186.7
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 169.0
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 162.2
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 161.9
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 158.7
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 158.5
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 157.2
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 156.8
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 154.8
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 150.9
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 149.2
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 148.0
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 144.4
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 142.6
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 141.3
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 138.7
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 135.8
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 128.1
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 120.4
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 115.0
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 114.6
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 114.4
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 110.8
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 107.4
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 106.6
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 95.3
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 94.4
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 93.6
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 93.5
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 88.7
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 86.3
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 83.9
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 80.5
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 76.8
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 76.6
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 65.9
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 55.8
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 53.7
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 47.6
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 42.1
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 32.4
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 31.4
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 26.4
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 20.2
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 19.7
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 17.8
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 5.5
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 3.3
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 2.1
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 1.2
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 0.7
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 0.7
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 0.3
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

ITIH4 is potential prognostic, high expression is favorable in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 690.85
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 1125.6
Number of samples 231
Samples
Sample Description pTPM
DO23548 78 years, female, NA, stage:1, alive, 840 days 3904.6
DO45215 65 years, male, NA, stage:2, alive, 1170 days 3704.1
DO45167 67 years, male, NA, stage:2, dead, 1440 days 3687.8
DO48721 58 years, female, NA, stage:1, alive, 900 days 3681.8
DO50807 67 years, male, NA, stage:1, alive, 540 days 3487.6
DO227801 77 years, female, NA, stage:1, alive, 660 days 3432.7
DO48760 70 years, female, NA, stage:2, alive, 690 days 3270.9
DO23550 69 years, male, NA, stage:1, alive, 990 days 3191.9
DO50813 56 years, male, NA, stage:2, alive, 420 days 3140.8
DO23544 67 years, male, NA, stage:2, alive, 960 days 3084.7
DO45159 65 years, male, NA, stage:3, alive, 1470 days 2976.2
DO45229 74 years, male, NA, stage:1, alive, 990 days 2964.5
DO45195 62 years, male, NA, stage:1, alive, 390 days 2950.9
DO45094 76 years, male, NA, stage:3, alive, 1650 days 2942.3
DO50850 74 years, male, NA, stage:3, alive, 720 days 2756.1
DO48677 58 years, male, NA, stage:3, alive, 1140 days 2701.2
DO48674 80 years, male, NA, stage:2, alive, 1260 days 2569.2
DO45107 63 years, female, NA, stage:2, alive, 1710 days 2496.9
DO48693 71 years, male, NA, stage:2, alive, 900 days 2474.5
DO227643 79 years, male, NA, stage:2, alive, 1260 days 2442.9
DO23517 62 years, male, NA, stage:2, alive, 1200 days 2372.4
DO45199 86 years, female, NA, stage:2, alive, 1350 days 2315.2
DO50774 68 years, female, NA, stage:2, alive, 720 days 2312.8
DO50787 63 years, male, NA, stage:3, alive, 480 days 2266.1
DO23538 67 years, male, NA, stage:2, alive, 450 days 2265.5
DO23536 56 years, male, NA, stage:2, alive, 930 days 2243.6
DO45113 58 years, male, NA, stage:3, alive, 1560 days 2224.4
DO23532 71 years, female, NA, stage:1, alive, 960 days 2221.1
DO45241 49 years, male, NA, stage:1, alive, 1080 days 2169.8
DO48682 72 years, female, NA, stage:3, dead, 120 days 2156.3
DO23531 78 years, female, NA, stage:3, alive, 900 days 2131.9
DO45261 74 years, male, NA, stage:3, alive, 990 days 2123.0
DO23512 60 years, male, NA, stage:1, alive, 1260 days 2112.6
DO50818 65 years, male, NA, stage:2, alive, 510 days 2041.8
DO50822 66 years, male, NA, stage:2, alive, 510 days 1979.2
DO45181 84 years, female, NA, stage:2, alive, 1200 days 1964.4
DO23551 73 years, male, NA, stage:3, dead, 150 days 1950.9
DO48746 76 years, male, NA, stage:3, alive, 570 days 1942.7
DO23525 71 years, male, NA, stage:4, alive, 1050 days 1941.7
DO48727 81 years, female, NA, stage:2, dead, 390 days 1937.9
DO23527 72 years, male, NA, stage:1, alive, 1050 days 1929.3
DO50804 81 years, male, NA, stage:2, alive, 720 days 1916.9
DO45191 61 years, female, NA, stage:2, alive, 1200 days 1913.8
DO50817 75 years, male, NA, stage:2, alive, 390 days 1897.1
DO23533 61 years, male, NA, stage:2, alive, 900 days 1877.4
DO45133 64 years, male, NA, stage:3, dead, 660 days 1863.7
DO50789 73 years, female, NA, stage:2, alive, 570 days 1802.0
DO23543 63 years, male, NA, stage:2, alive, 1020 days 1794.2
DO48743 69 years, female, NA, stage:2, alive, 570 days 1746.3
DO50819 72 years, female, NA, stage:2, alive, 510 days 1726.6
DO23518 67 years, male, NA, stage:2, alive, 1320 days 1714.3
DO48704 68 years, female, NA, stage:3, alive, 750 days 1695.4
DO45207 68 years, male, NA, stage:1, alive, 1050 days 1679.2
DO45125 58 years, male, NA, stage:3, alive, 1680 days 1674.4
DO23534 60 years, male, NA, stage:2, alive, 840 days 1670.8
DO45163 76 years, male, NA, stage:2, alive, 960 days 1637.5
DO45179 78 years, female, NA, stage:2, alive, 600 days 1628.5
DO50857 72 years, male, NA, stage:2, alive, 210 days 1597.3
DO48719 80 years, male, NA, stage:2, alive, 690 days 1569.0
DO50845 72 years, male, NA, stage:3, alive, 210 days 1557.1
DO45141 73 years, male, NA, stage:2, alive, 1320 days 1552.8
DO50798 77 years, male, NA, stage:3, dead, 30 days 1548.9
DO45101 63 years, male, NA, stage:2, alive, 1680 days 1544.8
DO23529 72 years, male, NA, stage:4, alive, 930 days 1510.3
DO50793 76 years, male, NA, stage:4, alive, 540 days 1463.2
DO45257 46 years, male, NA, stage:3, alive, 810 days 1435.4
DO48695 77 years, male, NA, stage:2, alive, 720 days 1430.5
DO45231 84 years, male, NA, stage:2, alive, 930 days 1427.9
DO45129 61 years, male, NA, stage:3, alive, 1470 days 1420.2
DO48716 71 years, male, NA, stage:2, alive, 720 days 1414.5
DO50816 63 years, male, NA, stage:2, alive, 390 days 1405.9
DO50800 74 years, male, NA, stage:2, alive, 510 days 1395.8
DO48733 72 years, male, NA, stage:2, alive, 600 days 1351.5
DO50803 62 years, female, NA, stage:1, alive, 540 days 1347.8
DO45197 51 years, male, NA, stage:2, alive, 1170 days 1345.1
DO50802 49 years, male, NA, stage:2, alive, 930 days 1342.2
DO45235 68 years, female, NA, stage:1, alive, 900 days 1329.0
DO45225 69 years, male, NA, stage:1, alive, 1050 days 1302.5
DO45123 78 years, female, NA, stage:2, dead, 570 days 1256.4
DO45253 50 years, male, NA, stage:2, alive, 870 days 1243.3
DO45091 56 years, male, NA, stage:2, dead, 1320 days 1229.4
DO45227 57 years, female, NA, stage:2, alive, 1020 days 1227.3
DO50776 75 years, male, NA, stage:1, alive, 690 days 1217.2
DO48742 76 years, male, NA, stage:2, alive, 600 days 1216.2
DO45255 81 years, male, NA, stage:3, alive, 720 days 1210.5
DO45169 74 years, male, NA, stage:3, alive, 1350 days 1197.6
DO50855 47 years, male, NA, stage:2, alive, 570 days 1192.2
DO45097 69 years, male, NA, stage:3, alive, 1620 days 1190.6
DO50832 73 years, male, NA, stage:3, alive, 90 days 1182.5
DO23541 65 years, male, NA, stage:2, alive, 930 days 1182.4
DO23549 74 years, male, NA, stage:3, alive, 990 days 1167.9
DO45157 62 years, male, NA, stage:2, alive, 1980 days 1166.4
DO23546 63 years, male, NA, stage:2, alive, 1050 days 1163.0
DO45177 81 years, female, NA, stage:3, alive, 1260 days 1161.6
DO50839 47 years, female, NA, stage:3, alive, 330 days 1155.3
DO45149 70 years, female, NA, stage:2, alive, 1260 days 1141.6
DO48761 55 years, male, NA, stage:2, alive, 870 days 1126.9
DO48701 78 years, male, NA, stage:2, alive, 780 days 1118.9
DO50859 77 years, male, NA, stage:2, alive, 180 days 1097.3
DO45109 63 years, male, NA, stage:2, alive, 1590 days 1072.9
DO50840 49 years, male, NA, stage:2, alive, 330 days 1067.5
DO45201 49 years, male, NA, stage:1, alive, 900 days 1054.4
DO23514 64 years, male, NA, stage:2, alive, 1290 days 1044.8
DO45219 78 years, male, NA, stage:2, alive, 1080 days 1041.2
DO48715 58 years, female, NA, stage:2, dead, 690 days 1032.1
DO48700 78 years, female, NA, stage:2, alive, 810 days 1032.0
DO45233 83 years, male, NA, stage:3, alive, 900 days 1029.4
DO45153 77 years, female, NA, stage:2, alive, 1380 days 1024.1
DO48712 50 years, male, NA, stage:2, alive, 810 days 1008.3
DO45155 69 years, male, NA, stage:2, alive, 2160 days 1003.8
DO23524 71 years, female, NA, stage:2, alive, 1050 days 995.0
DO45111 74 years, male, NA, stage:2, alive, 1590 days 994.1
DO45213 58 years, male, NA, stage:1, alive, 1200 days 990.8
DO45143 69 years, male, NA, stage:3, alive, 1290 days 978.2
DO45175 74 years, male, NA, stage:2, alive, 1140 days 977.3
DO23509 60 years, male, NA, stage:3, dead, 780 days 968.2
DO45099 46 years, male, NA, stage:3, alive, 1590 days 960.9
DO45095 66 years, male, NA, stage:2, alive, 1620 days 958.2
DO45203 71 years, female, NA, stage:2, alive, 1170 days 946.9
DO48723 73 years, male, NA, stage:1, alive, 600 days 926.8
DO45223 67 years, male, NA, stage:4, alive, 1020 days 918.1
DO50809 56 years, male, NA, stage:3, dead, 720 days 908.5
DO50783 62 years, male, NA, stage:3, alive, 480 days 906.5
DO48732 73 years, male, NA, stage:3, alive, 630 days 900.6
DO45273 62 years, male, NA, stage:2, alive, 480 days 899.9
DO45263 67 years, male, NA, stage:3, dead, 270 days 897.6
DO45135 77 years, male, NA, stage:1, alive, 1410 days 884.0
DO45187 32 years, female, NA, stage:1, alive, 1260 days 876.8
DO45117 73 years, female, NA, stage:2, dead, 1110 days 870.6
DO45281 83 years, male, NA, stage:4, alive, 750 days 869.0
DO45137 38 years, male, NA, stage:1, alive, 1320 days 864.0
DO23542 66 years, male, NA, stage:3, alive, 960 days 835.8
DO45103 47 years, male, NA, stage:3, alive, 450 days 824.1
DO45237 58 years, male, NA, stage:2, alive, 900 days 820.4
DO48725 66 years, male, NA, stage:1, alive, 780 days 812.4
DO23540 73 years, male, NA, stage:1, alive, 750 days 810.3
DO45183 72 years, female, NA, stage:2, dead, 570 days 798.6
DO45105 61 years, male, NA, stage:1, alive, 1680 days 794.5
DO45092 62 years, male, NA, stage:4, dead, 1200 days 781.5
DO45269 59 years, male, NA, stage:3, alive, 750 days 768.8
DO23510 80 years, female, NA, stage:2, alive, 870 days 765.1
DO48679 72 years, male, NA, stage:2, alive, 1200 days 763.8
DO50791 79 years, female, NA, stage:1, dead, 480 days 751.6
DO45243 74 years, female, NA, stage:3, alive, 930 days 749.9
DO50811 62 years, male, NA, stage:1, alive, 450 days 744.4
DO48672 81 years, male, NA, stage:2, alive, 450 days 740.7
DO45239 42 years, male, NA, stage:2, alive, 870 days 715.8
DO50820 77 years, female, NA, stage:3, alive, 510 days 706.4
DO23539 77 years, male, NA, stage:1, alive, 1110 days 706.2
DO45165 75 years, male, NA, stage:2, alive, 690 days 701.8
DO48759 73 years, male, NA, stage:3, alive, 720 days 690.8
DO45096 69 years, male, NA, stage:2, dead, 1290 days 681.2
DO45115 81 years, male, NA, stage:2, alive, 840 days 681.2
DO23521 63 years, male, NA, stage:3, alive, 1110 days 679.7
DO23516 69 years, male, NA, stage:3, dead, 20 days 676.0
DO50778 60 years, male, NA, stage:4, alive, 630 days 669.1
DO50806 70 years, male, NA, stage:4, alive, 540 days 641.7
DO50814 83 years, male, NA, stage:3, alive, 420 days 632.8
DO23537 79 years, male, NA, stage:2, dead, 900 days 614.1
DO23511 83 years, female, NA, stage:3, dead, 180 days 612.2
DO45265 73 years, male, NA, stage:3, alive, 1020 days 604.7
DO45131 53 years, male, NA, stage:4, dead, 360 days 584.9
DO45221 75 years, female, NA, stage:4, dead, 390 days 583.6
DO23535 67 years, male, NA, stage:1, alive, 960 days 583.3
DO23528 45 years, female, NA, stage:2, alive, 1020 days 577.9
DO45121 61 years, male, NA, stage:3, alive, 1530 days 573.8
DO45171 56 years, male, NA, stage:3, alive, 600 days 571.0
DO48737 52 years, male, NA, stage:1, alive, 720 days 563.5
DO45161 74 years, male, NA, stage:2, dead, 540 days 536.3
DO48717 54 years, male, NA, stage:4, dead, 180 days 534.7
DO50805 72 years, male, NA, stage:2, alive, 690 days 529.7
DO50808 68 years, male, NA, stage:2, alive, 570 days 528.6
DO45267 73 years, male, NA, stage:3, dead, 570 days 524.5
DO45173 63 years, male, NA, stage:3, alive, 1170 days 519.3
DO48736 76 years, female, NA, stage:1, alive, 600 days 517.4
DO23547 74 years, male, NA, stage:1, alive, 1020 days 517.0
DO45217 69 years, female, NA, stage:3, dead, 270 days 392.2
DO48706 72 years, male, NA, stage:2, alive, 870 days 385.3
DO23545 67 years, male, NA, stage:2, dead, 570 days 383.0
DO23530 53 years, male, NA, stage:4, dead, 180 days 380.6
DO48751 68 years, male, NA, stage:2, dead, 480 days 370.8
DO48730 73 years, female, NA, stage:2, alive, 630 days 365.5
DO45139 63 years, male, NA, stage:3, alive, 1320 days 349.4
DO48720 62 years, female, NA, stage:2, alive, 570 days 348.1
DO48697 64 years, female, NA, stage:2, dead, 810 days 345.6
DO48728 74 years, female, NA, stage:2, alive, 150 days 343.8
DO48681 57 years, male, NA, stage:2, alive, 900 days 342.4
DO45247 31 years, female, NA, stage:2, alive, 210 days 317.1
DO45119 74 years, male, NA, stage:3, dead, 510 days 294.5
DO23519 65 years, male, NA, stage:3, alive, 630 days 283.5
DO45185 89 years, male, NA, stage:2, alive, 600 days 273.1
DO45251 57 years, female, NA, stage:2, alive, 900 days 257.9
DO50825 70 years, male, NA, stage:2, alive, 390 days 247.5
DO45249 57 years, male, NA, stage:1, alive, 630 days 238.4
DO45275 65 years, male, NA, stage:3, dead, 10 days 209.9
DO45093 71 years, male, NA, stage:2, dead, 720 days 203.8
DO23552 80 years, female, NA, stage:1, alive, 810 days 198.9
DO23508 79 years, female, NA, stage:2, alive, 390 days 198.0
DO23515 71 years, male, NA, stage:2, alive, 1230 days 194.6
DO45193 68 years, female, NA, stage:4, dead, 120 days 185.6
DO50844 75 years, male, NA, stage:4, alive, 300 days 178.9
DO48741 64 years, male, NA, stage:3, alive, 240 days 178.4
DO45301 56 years, male, NA, stage:2, dead, 1440 days 171.3
DO50799 66 years, female, NA, stage:2, alive, 540 days 168.9
DO23526 66 years, male, NA, stage:3, alive, 1050 days 142.9
DO23513 76 years, male, NA, stage:3, alive, 1200 days 137.1
DO50785 37 years, male, NA, stage:4, dead, 90 days 125.0
DO50829 78 years, male, NA, stage:3, alive, 570 days 122.6
DO45209 70 years, male, NA, stage:4, alive, 1350 days 116.7
DO45205 67 years, female, NA, stage:2, dead, 90 days 114.0
DO45283 60 years, male, NA, stage:3, alive, 510 days 96.7
DO50815 62 years, male, NA, stage:3, alive, 150 days 80.1
DO45279 67 years, male, NA, stage:3, alive, 1290 days 69.3
DO45305 66 years, male, NA, stage:4, alive, 300 days 52.6
DO45289 78 years, female, NA, stage:3, alive, 360 days 49.0
DO45127 73 years, male, NA, stage:3, dead, 420 days 44.6
DO45287 74 years, male, NA, stage:1, alive, 390 days 41.7
DO45145 78 years, male, NA, stage:3, dead, 60 days 39.2
DO48747 62 years, male, NA, stage:3, alive, 540 days 36.8
DO45259 65 years, male, NA, stage:3, alive, 330 days 33.4
DO48757 68 years, female, NA, stage:3, alive, 480 days 29.4
DO45307 54 years, female, NA, stage:4, dead, 240 days 28.7
DO45277 64 years, male, NA, stage:3, alive, 600 days 22.1
DO45189 85 years, female, NA, stage:2, alive, 1200 days 20.5
DO23523 52 years, male, NA, stage:3, alive, 1080 days 16.0
DO45297 61 years, female, NA, stage:4, dead, 1260 days 10.4
DO45245 75 years, female, NA, stage:2, dead, 240 days 9.0
DO45285 59 years, male, NA, stage:3, alive, 480 days 7.4
DO45303 62 years, female, NA, stage:3, alive, 990 days 4.1
DO45299 70 years, female, NA, stage:1, alive, 1440 days 4.0
DO45211 76 years, male, NA, stage:3, alive, 240 days 2.4
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
343 Tumor 1.5
877 Tumor 1.3
425 Tumor 1.2
135 Tumor 1.1
192 Normal 1.1
112 Tumor 1.0
813 Tumor 0.9
445 Tumor 0.7
671 Tumor 0.7
863 Tumor 0.7
697 Tumor 0.7
665 Tumor 0.6
1045 Tumor 0.6
745 Tumor 0.6
391 Tumor 0.6
713 Tumor 0.6
224 Normal 0.6
615 Tumor 0.6
393 Tumor 0.6
778 Normal 0.5
375 Tumor 0.5
672 Normal 0.5
354 Normal 0.5
1041 Tumor 0.5
217 Tumor 0.5
125 Tumor 0.4
884 Normal 0.4
395 Tumor 0.4
137 Tumor 0.4
384 Normal 0.4
635 Tumor 0.4
444 Normal 0.4
344 Normal 0.4
342 Normal 0.4
232 Normal 0.4
857 Tumor 0.4
777 Tumor 0.4
636 Normal 0.4
364 Normal 0.4
396 Normal 0.4
568 Normal 0.3
392 Normal 0.3
536 Normal 0.3
558 Normal 0.3
368 Normal 0.3
228 Normal 0.3
142 Normal 0.3
1022 Normal 0.3
452 Normal 0.3
572 Normal 0.3
341 Tumor 0.3
218 Normal 0.3
1044 Normal 0.3
818 Normal 0.3
352 Normal 0.3
785 Tumor 0.3
113 Tumor 0.3
431 Tumor 0.3
981 Tumor 0.3
353 Tumor 0.3
148 Normal 0.3
642 Normal 0.3
744 Normal 0.3
746 Normal 0.3
618 Normal 0.3
426 Normal 0.3
223 Tumor 0.3
574 Normal 0.3
376 Normal 0.3
924 Normal 0.2
954 Normal 0.2
817 Tumor 0.2
686 Normal 0.2
456 Normal 0.2
535 Tumor 0.2
286 Normal 0.2
498 Normal 0.2
424 Normal 0.2
722 Normal 0.2
468 Normal 0.2
816 Normal 0.2
573 Tumor 0.2
126 Normal 0.2
111 Normal 0.2
187 Tumor 0.2
383 Tumor 0.2
563 Tumor 0.2
695 Tumor 0.2
363 Tumor 0.2
261 Tumor 0.2
526 Normal 0.2
141 Tumor 0.2
557 Tumor 0.2
191 Tumor 0.2
1015 Tumor 0.2
696 Normal 0.2
146 Normal 0.2
414 Normal 0.2
467 Tumor 0.2
358 Normal 0.2
984 Normal 0.2
394 Normal 0.2
327 Tumor 0.2
386 Normal 0.2
145 Tumor 0.2
814 Normal 0.2
1046 Normal 0.2
721 Tumor 0.2
564 Normal 0.1
528 Normal 0.1
514 Normal 0.1
365 Tumor 0.1
938 Normal 0.1
546 Normal 0.1
982 Normal 0.1
862 Normal 0.1
958 Normal 0.1
666 Normal 0.1
432 Normal 0.1
866 Normal 0.1
464 Normal 0.1
882 Normal 0.1
616 Normal 0.1
195 Tumor 0.1
523 Tumor 0.1
878 Normal 0.1
953 Tumor 0.1
647 Tumor 0.1
428 Normal 0.1
488 Normal 0.1
388 Normal 0.1
648 Normal 0.1
423 Tumor 0.1
723 Tumor 0.1
824 Normal 0.1
446 Normal 0.1
858 Normal 0.1
284 Normal 0.1
186 Normal 0.1
1026 Normal 0.1
138 Normal 0.1
196 Normal 0.1
421 Tumor 0.1
455 Tumor 0.1
737 Tumor 0.1
422 Normal 0.1
221 Tumor 0.1
968 Normal 0.1
823 Tumor 0.1
124 Normal 0.1
627 Tumor 0.1
786 Normal 0.1
937 Tumor 0.1
448 Normal 0.1
663 Tumor 0.1
297 Tumor 0.1
742 Normal 0.1
741 Tumor 0.0
494 Normal 0.0
517 Tumor 0.0
628 Normal 0.0
114 Normal 0.0
738 Normal 0.0
864 Normal 0.0
268 Normal 0.0
571 Tumor 0.0
451 Tumor 0.0
515 Tumor 0.0
527 Tumor 0.0
136 Normal 0.0
716 Normal 0.0
132 Normal 0.0
524 Normal 0.0
956 Normal 0.0
1042 Normal 0.0
462 Normal 0.0
952 Normal 0.0
912 Normal 0.0
332 Normal 0.0
868 Normal 0.0
756 Normal 0.0
914 Normal 0.0
728 Normal 0.0
915 Tumor 0.0
466 Normal 0.0
312 Normal 0.0
147 Tumor 0.0
162 Normal 0.0
685 Tumor 0.0
881 Tumor 0.0
185 Tumor 0.0
214 Normal 0.0
262 Normal 0.0
298 Normal 0.0
922 Normal 0.0
714 Normal 0.0
461 Tumor 0.0
487 Tumor 0.0
1028 Normal 0.0
188 Normal 0.0
975 Tumor 0.0
474 Normal 0.0
554 Normal 0.0
314 Normal 0.0
662 Normal 0.0
918 Normal 0.0
553 Tumor -0.1
328 Normal -0.1
944 Normal -0.1
257 Tumor -0.1
664 Normal -0.1
983 Tumor -0.1
433 Tumor -0.1
1016 Normal -0.1
258 Normal -0.1
172 Normal -0.1
916 Normal -0.1
617 Tumor -0.1
447 Tumor -0.1
715 Tumor -0.1
283 Tumor -0.1
465 Tumor -0.1
222 Normal -0.1
434 Normal -0.1
212 Normal -0.1
641 Tumor -0.1
416 Normal -0.1
484 Normal -0.1
472 Normal -0.1
443 Tumor -0.1
538 Normal -0.1
1014 Normal -0.1
366 Normal -0.1
698 Normal -0.1
883 Tumor -0.1
516 Normal -0.1
481 Tumor -0.1
874 Normal -0.1
128 Normal -0.1
852 Normal -0.1
1043 Tumor -0.1
851 Tumor -0.1
463 Tumor -0.1
926 Normal -0.1
917 Tumor -0.1
755 Tumor -0.1
492 Normal -0.2
861 Tumor -0.2
356 Normal -0.2
272 Normal -0.2
534 Normal -0.2
976 Normal -0.2
967 Tumor -0.2
436 Normal -0.2
227 Tumor -0.2
513 Tumor -0.2
278 Normal -0.2
525 Tumor -0.2
267 Tumor -0.2
482 Normal -0.2
913 Tumor -0.2
471 Tumor -0.2
518 Normal -0.2
873 Tumor -0.2
1021 Tumor -0.2
412 Normal -0.2
815 Tumor -0.2
362 Normal -0.2
161 Tumor -0.2
311 Tumor -0.2
567 Tumor -0.2
361 Tumor -0.2
478 Normal -0.2
285 Tumor -0.3
213 Tumor -0.3
491 Tumor -0.3
727 Tumor -0.3
966 Normal -0.3
1032 Normal -0.3
415 Tumor -0.3
545 Tumor -0.3
923 Tumor -0.3
911 Tumor -0.3
957 Tumor -0.3
867 Tumor -0.3
977 Tumor -0.3
413 Tumor -0.3
351 Tumor -0.3
427 Tumor -0.3
943 Tumor -0.3
964 Normal -0.3
865 Tumor -0.3
743 Tumor -0.4
955 Tumor -0.4
724 Normal -0.4
387 Tumor -0.4
978 Normal -0.4
331 Tumor -0.4
367 Tumor -0.4
277 Tumor -0.4
483 Tumor -0.4
1025 Tumor -0.4
497 Tumor -0.4
355 Tumor -0.5
131 Tumor -0.5
921 Tumor -0.5
271 Tumor -0.5
127 Tumor -0.5
357 Tumor -0.6
477 Tumor -0.6
123 Tumor -0.6
231 Tumor -0.6
951 Tumor -0.6
385 Tumor -0.6
963 Tumor -0.6
411 Tumor -0.6
965 Tumor -0.7
493 Tumor -0.8
435 Tumor -0.8
925 Tumor -0.8
171 Tumor -0.8
1027 Tumor -0.9
313 Tumor -0.9
533 Tumor -1.0
1013 Tumor -1.0
1031 Tumor -1.0
211 Tumor -1.1
661 Tumor -1.2
537 Tumor -1.3
473 Tumor -1.4
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA001835

Antibody HPA003948

Antibody CAB072872
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Carcinoma, Hepatocellular, NOS
Cholangiocarcinoma

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org